Netobimin

This classification denotes an antihelminthic agent with the molecular formula C14H20N4O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U30C54N3MU, chemically known as ethanesulfonic acid, 2-((((methoxycarbonyl)amino)((2-nitro-5-(propylthio)phenyl)imino)methyl)amino)- but generally known as netobimin, which bears US NIH Compound Identifier 71449. European Medicines Agency schedules Netobimin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09212MIG. The term NETOBIMIN is an International Non-Proprietary Name. NETOBIMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule netobimin under HS 29309085 and SITC 51549. As of Q4 2014, NETOBIMIN remains the US FDA Preferred Term for this commodity. Netobimin bears US NLM identifiers UMLS ID C0068578 and NCI Concept Code C66238. SMILES: S(=O)(=O)(O)CC/N=C(/NC1C([N](=O)O)CCC(SCCC)C1)NC(=O)OC.